EDW PHARMA, INC.
PAOLI, PA


ITF PHARMA, INC.

EDW PHARMA, INC. began its journey as ITF PHARMA, INC., before embracing its current identity as a subsidiary of Italfarmaco S.p.A.-a private European company specializing in niche pharmaceuticals. Founded on December 28, 2015, this Florida-incorporated business calls Paoli, Pennsylvania, home and is dedicated to developing and distributing both prescription and over-the-counter medications across fields like cardiology, thrombosis, oncology/supportive care, CNS disorders, bone metabolism, and women's health. The company can be reached at their mailing address of 3 Paoli Plaza in Paoli, PA, with a main phone line for contact (484) 328-4964. They also offer a toll-free number (800) 664-1490 and an additional line at (480) 632-5600. Interested parties can find more information on their website, itfpharma.com. In early 2024, EDW PHARMA, INC. officially updated its name in corporate records, a change noted in the annual report filed on January 17, 2024. The company's Federal Employer Identification Number for official purposes is 81-0876632. Among the key figures steering the organization are Peter Cook as a Director and Michael Smith serving as Chief Financial Officer (CFO).

KEY FACTS ABOUT EDW PHARMA, INC.

Company name
EDW PHARMA, INC.
Status
Active
Filed Number
F15000005722
FEI Number
81-0876632
Date of Incorporation
December 28, 2015
Age - 11 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
https://itfpharma.com
Phones
(484) 328-4964
(800) 664-1490
(480) 632-5600

EDW PHARMA, INC. NEAR ME

Principal Address
3 PAOLI PLAZA,
PAOLI,
PA,
19301,
US

See Also

Officers and Directors

The EDW PHARMA, INC. managed by the two persons from PAOLI on following positions: Director, CFO

Peter Cook

Position
Director Active
From
PAOLI, PA, PA

Michael Smith

Position
CFO Active
From
PAOLI, PA, PA





Registered Agent is REGISTERED AGENT SOLUTIONS, INC.

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

April 5, 2024
NAME CHANGE AMENDMENT

Annual Reports

2025
March 19, 2025
2024
January 17, 2024